CM
MDGL icon

Castleark Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Castleark Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.77M Sell
5,296
-9,170
-63% -$4.38M 0.09% 187
2025
Q4 		$8.42M Buy
14,466
+4,540
+46% +$2.32M 0.25% 86
2025
Q3 		$4.55M Buy
+9,926
New +$3.7M 0.13% 151
2025
Q2 		– Sell
-10,580
Closed -$3.5M – 317
2025
Q1 		$3.5M Buy
+10,580
New +$3.48M 0.12% 153
2024
Q3 		– Sell
-9,130
Closed -$2.56M – 294
2024
Q2 		$2.56M Sell
9,130
-80
-0.9% -$19K 0.1% 162
2024
Q1 		$2.46M Buy
+9,210
New +$2.17M 0.1% 168
2023
Q3 		– Sell
-9,560
Closed -$2.21M – 301
2023
Q2 		$2.21M Buy
+9,560
New +$2.59M 0.1% 159

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return